UROONCO RCC associate editor Dr. Teele Kuusk interviews Dr. Zayd Tippu on his EAU26 lecture “Decoding the evolutionary biology of kidney cancer: Insights from the primary tumour to precision therapy”.
This interview discusses the biological complexity of kidney cancer, focusing on tumour genomics, heterogeneity, and metastatic potential. Key topics include predictive biomarkers, challenges in implementing molecular tools, and advances in neoadjuvant immunotherapy. Their conversation also covers treatment strategies in metastatic disease, including nephrectomy timing and therapy discontinuation. Emphasis is placed on personalised, biology-driven decision-making and the future integration of composite biomarkers to improve patient outcomes.
To learn more, you can also watch the webcast recording of this lecture.